TDGF1 anticorps (N-Term)
Aperçu rapide pour TDGF1 anticorps (N-Term) (ABIN363493)
Antigène
Voir toutes TDGF1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Reacts with mouse ~18 kDa (core form) and ~36 kDa (glycosylated/ post-transcriptionally modified form) TDGF1 protein
-
Réactivité croisée (Details)
- May cross reacts with human protein. (78 % sequence homology).
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic peptide made to an N-terminal portion of the murine cripto protein sequence
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- WB : 1/500 to 1/2 000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C. Do not freeze.
-
-
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Autre désignation
- Teratocarcinoma-Derived Growth Factor 1
-
Pathways
- EGFR Signaling Pathway
Antigène
-